|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of TCR2 Therapeutics (NASDAQ: TCRR) through any online brokerage.
The latest price target for TCR2 Therapeutics (NASDAQ: TCRR) was reported by SVB Leerink on March 11, 2021. The analyst firm set a price target for 34.00 expecting TCRR to rise to within 12 months (a possible 89.94% upside). 10 analyst firms have reported ratings in the last year.
The stock price for TCR2 Therapeutics (NASDAQ: TCRR) is $17.9 last updated Today at 7:04:18 PM.
There are no upcoming dividends for TCR2 Therapeutics.
There is no upcoming split for TCR2 Therapeutics.
TCR2 Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.